INS and type 2 diabetes mellitus: The COVID-19 pandemic has impacted access to care and may have contributed to the reduction in insulin treatment visits and health care utilization.30 Prior surveillance reports of insulin use in the United States have relied on patient self-report and include younger adults, who may be more likely to have type 1 diabetes31; in contrast, the data for our study use information taken directly from physician encounter forms and focuses on adults with type 2 diabetes.